Molecular analysis and organization of the sigmaB operon in Staphylococcus aureus.

Department of Medical Microbiology, University of Zürich, Switzerland.
Journal of Bacteriology (Impact Factor: 2.69). 01/2006; 187(23):8006-19. DOI: 10.1128/JB.187.23.8006-8019.2005
Source: PubMed

ABSTRACT The alternative sigma factor sigma(B) of Staphylococcus aureus controls the expression of a variety of genes, including virulence determinants and global regulators. Genetic manipulations and transcriptional start point (TSP) analyses showed that the sigB operon is transcribed from at least two differentially controlled promoters: a putative sigma(A)-dependent promoter, termed sigB(p1), giving rise to a 3.6-kb transcript covering sa2059-sa2058-rsbU-rsbV-rsbW-sigB, and a sigma(B)-dependent promoter, sigB(p3), initiating a 1.6-kb transcript covering rsbV-rsbW-sigB. TSP and promoter-reporter gene fusion experiments indicated that a third promoter, tentatively termed sigB(p2) and proposed to lead to a 2.5-kb transcript, including rsbU-rsbV-rsbW-sigB, might govern the expression of the sigB operon. Environmental stresses, such as heat shock and salt stress, induced a rapid response within minutes from promoters sigB(p1) and sigB(p3). In vitro, the sigB(p1) promoter was active in the early growth stages, while the sigB(p2) and sigB(p3) promoters produced transcripts throughout the growth cycle, with sigB(p3) peaking around the transition state between exponential growth and stationary phase. The amount of sigB transcripts, however, did not reflect the concentration of sigma(B) measured in cell extracts, which remained constant over the entire growth cycle. In a guinea pig cage model of infection, sigB transcripts were as abundant 2 and 8 days postinoculation as values found in vitro, demonstrating that sigB is indeed transcribed during the course of infection. Physical interactions between staphylococcal RsbU-RsbV, RsbV-RsbW, and RsbW-sigma(B) were inferred from a yeast (Saccharomyces cerevisiae) two-hybrid approach, indicating the presence of a partner-switching mechanism in the sigma(B) activation cascade similar to that of Bacillus subtilis. The finding that overexpression of RsbU was sufficient to trigger an immediate and strong activation of sigma(B), however, signals a relevant difference in the regulation of sigma(B) activation between B. subtilis and S. aureus in the cascade upstream of RsbU.


Available from: Jan Kormanec, Jun 05, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: Four Staphylococcus aureus-Escherichia coli shuttle vectors were constructed for gene expression and production of tagged fusion protein. Vectors pBUS1-HC and pTSSCm are promoter-less for studying gene under control of their native promoter, and pBUS1-Pcap-HC and pTSSCm-Pcap contain the strong constitutive promoter of S. aureus type 1 capsule gene 1A (Pcap) upstream of a novel multiple cloning site (MCS) harboring codons for the peptide tag Arg-Gly-Ser-hexa-His (rgs-his6). All plasmids contained the backbone derived from pBUS1 including the E. coli origin ColE1, the terminator rrnB(T1)5 and the tetracycline resistance marker tet(L) for S. aureus and E. coli. Gram-positive replicon was improved through either complementation of the minimum pAMα1 replicon from pBUS1 with the single strand origin oriL from pUB110 (pBUS1-HC and pBUS1-Pcap-HC) or substitution with a pT181-family replicon (pTSSCm and pTSSCm-Pcap). The new constructs displayed increased plasmid yield and segregational stability in S. aureus. Furthermore, pBUS1-Pcap-HC and pTSSCm-Pcap offer the potential to generate C-terminal RGS-His6 translational fusions of cloned genes using simple molecular manipulation. BcgI-induced DNA excision followed by religation converts the TGA stop codon of the MCS into a TGC codon and links the rgs-his6 codons to the 3' end of the target gene. The generation of the rgs-his6 codon-fusion, gene expression and protein purification were demonstrated in both S. aureus and E. coli using the macrolide, lincosamide, streptogramin B resistance gene erm (44) inserted downstream of Pcap. The new His-tag expression system represents a helpful tool for the direct analysis of target gene function in staphylococcal cells. Copyright © 2015, American Society for Microbiology. All Rights Reserved.
    Applied and Environmental Microbiology 03/2015; 81(9). DOI:10.1128/AEM.03803-14 · 3.95 Impact Factor
  • Source
  • [Show abstract] [Hide abstract]
    ABSTRACT: We performed a genome-wide analysis using a next-generation sequencer to investigate the effect of pulmonary surfactant on gene expression in Staphylococcus aureus, a clinically important opportunistic pathogen. RNA-seq analysis of bacterial transcripts at late log-phase revealed 142 genes that were upregulated by more than 2-fold following the addition of pulmonary surfactant to the culture medium. Among these genes, we confirmed by quantitative reverse transcription-polymerase chain reaction analysis that mRNA amounts of genes encoding ESAT-6 secretion system C (EssC); an unknown hypothetical protein, NWMN_0246 (pulmonary surfactant-inducible factor A; PsiA); and hemolysin gamma subunit B (HlgB) were increased 3 to 10-fold by the surfactant treatment. Among the major constituents of pulmonary surfactant, phospholipids and palmitate, only palmitate, which is the most abundant fatty acid in the pulmonary surfactant and a known antibacterial substance, stimulated the expression of these three genes. Moreover, these genes were also induced by supplementing the culture with detergents. The induction of gene expression by surfactant or palmitate was not observed in a disruption mutant of the sigB gene that encodes an alternative sigma factor involved in bacterial stress responses. Furthermore, each disruption mutant of the essC, psiA, or hlgB gene showed attenuation of both survival in the lung and host killing ability in a murine pneumonia model. These findings suggest that S. aureus resists membrane stress caused by free fatty acids present in the pulmonary surfactant through the regulation of virulence gene expression, which contributes to its pathogenesis within the lungs of the host animal.
    Infection and immunity 01/2014; 82(4). DOI:10.1128/IAI.01635-13 · 4.16 Impact Factor